Cheelcare Inc. News Releases

Cheelcare Delivers First Curio Robotic Complex-Rehab Power Wheelchair to Paying Customers and Achieves Record Companion Sales

Thu, 09 Apr 2026 07:30:00 -0400

Markham, Ontario--(Newsfile Corp. - April 9, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced the delivery of its first Curio robotic complex-rehab power wheelchair to paying customers, marking the Company's transition into commercial production and initial revenue generation for its flagship power wheelchair platform.This milestone is complemented by record Companion unit sales in March,...

Cheelcare Announces Third Quarter 2026 Financial Results

Wed, 25 Mar 2026 07:30:00 -0400

Markham, Ontario--(Newsfile Corp. - March 25, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced its financial results for the third quarter ended January 31, 2026. All figures are in CAD unless otherwise noted.Operational Highlights (Three Months Ended January 31, 2026)Record quarterly revenue: The Company achieved its strongest quarterly performance to date, reflecting growing adoption of its...

Cheelcare Closes $1.0 Million Unsecured Note Financing

Wed, 18 Feb 2026 07:30:00 -0500

Markham, Ontario--(Newsfile Corp. - February 18, 2026) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced that it has closed its previously-announced offering of 12% unsecured promissory notes (the "Notes") for aggregate gross proceeds of $1,000,000 (the "Offering").The Offering was subscribed by Pathfinder Asset Management Ltd., which purchased $750,000 aggregate principal amount of Notes, and NameSilo Technologies...

Cheelcare Announces $1.0 Million Unsecured Note Financing

Mon, 09 Feb 2026 07:00:00 -0500

Markham, Ontario--(Newsfile Corp. - February 9, 2026) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced that it has entered into term sheets with strategic investors for a non-brokered unsecured promissory note (the "Notes") financing for gross proceeds of up to $1,000,000 (the "Offering").The Offering is expected to include $750,000 from Pathfinder Asset Management Ltd. ("PAML") and $250,000 from NameSilo...

Cheelcare Announces Medicare and Medicaid Services Reimbursement Approval for Companion Power Assist Device, Expanding U.S. Market Access

Mon, 26 Jan 2026 07:30:00 -0500

Investment Highlights:U.S. Medicare and Medicaid reimbursement eligibility achieved:The Company has received Pricing, Data Analysis, and Coding ("PDAC") verification, enabling U.S. Medicare and Medicaid reimbursement for its Companion power assist device. Companion is a best-in-class, front-mounted add-on for manual wheelchairs that provides motorized assistance, helping users enable a higher quality of life.Medicare and Medicaid funding removes a key barrier to customer adoption:Medicare...

Cheelcare Announces Second Quarter Fiscal 2026 Financial Results

Tue, 30 Dec 2025 16:30:00 -0500

Markham, Ontario--(Newsfile Corp. - December 30, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced its financial results for the second quarter ended October 31, 2025. All figures are in Canadian dollars unless otherwise noted.Operational Highlights (Three Months Ended October 31, 2025)Manufacturing transition completed: Successfully completed the transition of inventory, equipment, and production lines into...

Cheelcare Has a Record Month of Sales and Celebrates Milestone of 2,000 Companions Sold

Mon, 08 Dec 2025 07:00:00 -0500

Markham, Ontario--(Newsfile Corp. - December 8, 2025) - Cheelcare (TSXV: CHER), a Canadian innovator in advanced mobility solutions, is proud to announce that the Company has reached a major commercial milestone with the sale of its 2,000th Companion, coinciding with a record month of production and sales. This reflects accelerating market adoption and growing demand for innovative mobility solutions.The Companion is Cheelcare's flagship power-assist device, purpose-built to augment manual...

Cheelcare to Represent Canadian Health Innovation at Health Tech Forward 2025 in Barcelona

Tue, 02 Dec 2025 07:00:00 -0500

Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - Cheelcare (TSXV: CHER), a Canadian innovator in advanced mobility solutions, was selected to participate in a Canadian trade mission to Barcelona, Spain, from December 2-4, 2025. As part of this mission, Eugene Cherny, CEO of Cheelcare, will present during the "Active Mobility Innovation - Startup Pitches" at the prestigious Health Tech Forward 2025 Conference, showcasing Cheelcare's cutting-edge assistive mobility technology, including the...

Cheelcare Receives "Compliant" Rating from Health Canada Following Routine Inspection

Mon, 24 Nov 2025 07:00:00 -0500

Markham, Ontario--(Newsfile Corp. - November 24, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian leader in assistive mobility devices, has received a "Compliant" rating from Health Canada, following a routine regulatory inspection conducted between October 22 and November 3, 2025. The inspection was conducted at Cheelcare's new 16,000 sq. ft. manufacturing and R&D facility in Markham, which the Company began occupying this fall as part of its broader expansion...

Cheelcare Appoints Dave Jones as Director of U.S. Sales

Thu, 16 Oct 2025 08:00:00 -0400

Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian leader in assistive mobility devices, is pleased to announce the appointment of Dave Jones as Director of U.S. Sales, effective immediately.Mr. Jones brings over 30 years of executive sales and marketing experience in the complex rehabilitation and durable medical equipment (DME) sectors. His career includes senior roles at Drive Medical, Merits Healthcare, Quantum Rehab...